Literature DB >> 11854214

Characterization of humoral and cellular immune responses elicited by meningococcal carriage.

K Robinson1, K R Neal, C Howard, J Stockton, K Atkinson, E Scarth, J Moran, A Robins, I Todd, E Kaczmarski, S Gray, I Muscat, R Slack, D A A Ala'Aldeen.   

Abstract

In order to study the immune response elicited by asymptomatic carriage of Neisseria meningitidis, samples of serum, peripheral blood mononuclear cells (PBMCs), and saliva were collected from a cohort of more than 200 undergraduate students in Nottingham, United Kingdom, who were subject to high rates of acquisition and carriage of meningococci. Serum immunoglobulin G levels were elevated following increases in the rate of carriage, and these responses were specific for the colonizing strains. In order to investigate T-cell responses, PBMCs from 15 individuals were stimulated with a whole-cell lysate of the H44/76 meningococcal strain (B:15:P1.7,16), stained to detect cell surface markers and intracellular cytokines, and examined by flow cytometry. The cells were analyzed for expression of CD69 (to indicate activation), gamma interferon (IFN-gamma) (a representative T-helper 1 subset [Th1]-associated cytokine), and interleukin-5 (IL-5) (a Th2-associated cytokine). Following a brief meningococcal stimulation, the numbers of CD69(+) IFN-gamma(+) CD56/16(+) NK cells were much higher than cytokine-positive CD4(+) events. Both IFN-gamma(+) and IL-5(+) events were detected among the CD69(+) CD4(+) population, leading to the conclusion that an unbiased T-helper subset response was elicited by meningococcal carriage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854214      PMCID: PMC127751          DOI: 10.1128/IAI.70.3.1301-1309.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Salivary antibodies following parenteral immunization of infants with a meningococcal serogroup A and C conjugated vaccine.

Authors:  R Borrow; A J Fox; K Cartwright; N T Begg; D M Jones
Journal:  Epidemiol Infect       Date:  1999-10       Impact factor: 2.451

Review 2.  The role of IL-18 in innate immunity.

Authors:  S Akira
Journal:  Curr Opin Immunol       Date:  2000-02       Impact factor: 7.486

Review 3.  Oral tolerance: immune mechanisms and treatment of autoimmune diseases.

Authors:  H L Weiner
Journal:  Immunol Today       Date:  1997-07

Review 4.  Recognition and control of neisserial infection by antibody and complement.

Authors:  G A Jarvis
Journal:  Trends Microbiol       Date:  1995-05       Impact factor: 17.079

5.  Humoral immunity to commensal oral bacteria in human infants: salivary secretory immunoglobulin A antibodies reactive with Streptococcus mitis biovar 1, Streptococcus oralis, Streptococcus mutans, and Enterococcus faecalis during the first two years of life.

Authors:  M F Cole; S Bryan; M K Evans; C L Pearce; M J Sheridan; P A Sura; R L Wientzen; G H Bowden
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

6.  Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens.

Authors:  G Lertmemongkolchai; G Cai; C A Hunter; G J Bancroft
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

7.  Underestimation of meningococci in tonsillar tissue by nasopharyngeal swabbing.

Authors:  R J Sim; M M Harrison; E R Moxon; C M Tang
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

8.  Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS).

Authors:  H Uronen; A J Williams; G Dixon; S R Andersen; P Van Der Ley; M Van Deuren; R E Callard; N Klein
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

9.  IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production.

Authors:  J Yang; H Zhu; T L Murphy; W Ouyang; K M Murphy
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

10.  Vaccination against the nematode Trichinella spiralis in high- and low-responder mice. Effects of different adjuvants upon protective immunity and immune responsiveness.

Authors:  K Robinson; T Bellaby; D Wakelin
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

View more
  15 in total

1.  Sterilizing immunity elicited by Neisseria meningitidis carriage shows broader protection than predicted by serum antibody cross-reactivity in CEACAM1-humanized mice.

Authors:  Kay O Johswich; Shannon E McCaw; Lea Strobel; Matthias Frosch; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.

Authors:  K Robinson; L M Chamberlain; M C Lopez; C M Rush; H Marcotte; R W F Le Page; J M Wells
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

3.  Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage.

Authors:  Mohamed Alamro; Fadil A Bidmos; Hannah Chan; Neil J Oldfield; Emma Newton; Xilian Bai; Jack Aidley; Rory Care; Claire Mattick; David P J Turner; Keith R Neal; Dlawer A A Ala'aldeen; Ian Feavers; Ray Borrow; Christopher D Bayliss
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

4.  T-cell-stimulating protein A elicits immune responses during meningococcal carriage and human disease.

Authors:  Karen Robinson; Karl G Wooldridge; Damien B Wells; Amal Hasan; Ian Todd; Adrian Robins; Richard James; Dlawer A A Ala'Aldeen
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students.

Authors:  J Zoe Jordens; Jeannette N Williams; Graeme R Jones; Myron Christodoulides; John E Heckels
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

6.  Functional T-cell deficiency in adolescents who experience serogroup C meningococcal disease despite receiving the meningococcal serogroup C conjugate vaccine.

Authors:  Rachel A Foster; Jennifer Carlring; Andrew Lees; Ray Borrow; Mary Ramsay; Ed Kacsmarski; Elizabeth Miller; Michael W McKendrick; Andrew W Heath; Robert C Read
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

7.  Attenuation of monocyte proinflammatory cytokine responses to Neisseria meningitidis in children by erythropoietin.

Authors:  C Schultz; J Zimmer; C Härtel; J Rupp; P Temming; T Strunk
Journal:  Clin Exp Immunol       Date:  2008-09-08       Impact factor: 4.330

8.  Evidence of a functional B-cell immunodeficiency in adults who experience serogroup C meningococcal disease.

Authors:  Rachel A Foster; Jennifer Carlring; Michael W McKendrick; Andrew Lees; Ray Borrow; Robert C Read; Andrew W Heath
Journal:  Clin Vaccine Immunol       Date:  2009-03-11

9.  Neisseria meningitidis escape from the bactericidal activity of a monoclonal antibody is mediated by phase variation of lgtG and enhanced by a mutator phenotype.

Authors:  Christopher D Bayliss; J Claire Hoe; Katherine Makepeace; Patricia Martin; Derek W Hood; E Richard Moxon
Journal:  Infect Immun       Date:  2008-08-11       Impact factor: 3.441

10.  Antibody specificities and effect of meningococcal carriage in icelandic teenagers receiving the Norwegian serogroup B outer membrane vesicle vaccine.

Authors:  Elisabeth Wedege; Betsy Kuipers; Karin Bolstad; Harry van Dijken; L Oddvar Frøholm; Clementien Vermont; Dominique A Caugant; Germie van den Dobbelsteen
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.